Antithrombotic therapy in atrial fibrillation : stop triple therapy and start optimizing dual therapy?
Wernly, Bernhard ; Lichtenauer, Michael ; Erlinge, David LU
and Jung, Christian
(2020)
In Clinical Research in Cardiology
109(1).
p.128-130
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/489b2f53-e7c8-452c-8449-16f8938d3f5d
- author
- Wernly, Bernhard
; Lichtenauer, Michael
; Erlinge, David
LU
and Jung, Christian
- organization
- publishing date
- 2020-01
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Clinical Research in Cardiology
- volume
- 109
- issue
- 1
- pages
- 3 pages
- publisher
- Steinkopff
- external identifiers
-
- pmid:31144062
- scopus:85068833076
- ISSN
- 1861-0684
- DOI
- 10.1007/s00392-019-01496-w
- language
- English
- LU publication?
- yes
- id
- 489b2f53-e7c8-452c-8449-16f8938d3f5d
- date added to LUP
- 2019-07-24 16:28:18
- date last changed
- 2024-04-02 15:07:19
@article{489b2f53-e7c8-452c-8449-16f8938d3f5d,
author = {{Wernly, Bernhard and Lichtenauer, Michael and Erlinge, David and Jung, Christian}},
issn = {{1861-0684}},
language = {{eng}},
number = {{1}},
pages = {{128--130}},
publisher = {{Steinkopff}},
series = {{Clinical Research in Cardiology}},
title = {{Antithrombotic therapy in atrial fibrillation : stop triple therapy and start optimizing dual therapy?}},
url = {{http://dx.doi.org/10.1007/s00392-019-01496-w}},
doi = {{10.1007/s00392-019-01496-w}},
volume = {{109}},
year = {{2020}},
}